Business Wire

Glass Lewis Endorses Company’s Leadership and Strategy to Continue Delivering Stockholder Value

Firm Emphasizes Company’s Peer-Leading Operational Performance and Market-leading Position in Tokenization and Digital Assets

WisdomTree Urges Stockholders to Vote “FOR” ALL NINE of its Highly Qualified Director Nominees on the WHITE Proxy Card

NEW YORK--(BUSINESS WIRE)-- WisdomTree, Inc. (NYSE: WT), a global financial innovator, today announced that Glass... (continue reading...)

Association remained committed to serving the military community and their families and helping them build financial security amid economic headwinds.

SAN ANTONIO--(BUSINESS WIRE)-- USAA today published its 2023 Annual Report to Members, highlighting strong financial performance, membership growth and the introduction of innovative products and services to meet the needs of its members.

“Many of the economic challenges from 2022 continued into 2023,... (continue reading...)

PanCAN’s Know Your Tumor precision medicine service will be used to further validate Genialis krasID biomarker performance in pancreatic cancer

CHICAGO--(BUSINESS WIRE)-- Genialis, the RNA-biomarker company, today announced a new partnership with the Pancreatic Cancer Action Network (PanCAN) to expand the validation of the Genialis™ krasID biomarker in the pancreatic cancer histology. Genialis krasID is a new Artificial Intelligence classifier that accurately... (continue reading...)

BOSTON--(BUSINESS WIRE)-- HITEC Sensors today announced it received the BAE Systems ‘Partner 2 Win’ Supplier of the Year award. HITEC Sensors was selected from a pool of suppliers that delivered exceptional performance and contributions to supply chain success for BAE Systems’ Electronic Systems sector in 2023.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240531049861/en/

HITEC Sensors received... (continue reading...)

– Late-breaking data from phase 3 KONFIDENT trial of sebetralstat published in NEJM and presented concurrently at the European Academy of Allergy and Clinical Immunology Congress 2024 –

– Interim data from KONFIDENT-S open-label trial show median time to treatment of 9 minutes and median time to beginning of symptom relief for laryngeal attacks 1.3 hours –

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)-- KalVista Pharmaceuticals, Inc. (NASDAQ: ... (continue reading...)